Evaluation of Long Term Safety of Tesofensine in Patients With Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

November 30, 2008

Conditions
Obesity
Interventions
DRUG

Tesofensine

Trial Locations (1)

1958

Faculty of Life Sciences, University of Copenhagen, Copenhagen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NeuroSearch A/S

INDUSTRY

NCT00481104 - Evaluation of Long Term Safety of Tesofensine in Patients With Obesity | Biotech Hunter | Biotech Hunter